Western Sierra R Stock Price, News & Analysis
Company Description
Western Sierra R (OTC Link: WSRC) is a publicly traded drug manufacturers - specialty & generic company in the Healthcare sector. The company has a market capitalization of $67.4K.
WSRC stock has declined 80.0% over the past year. Shares last traded at $0.0001.
This page provides a comprehensive overview of WSRC stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Western Sierra R (WSRC) stock last traded at $0.0001. Over the past 12 months, the stock has lost 80.0%. At a market capitalization of $67.4K, WSRC is classified as a micro-cap stock with approximately 337.1M shares outstanding.
Latest News
Western Sierra R has 10 recent news articles. Of the recent coverage, 9 articles coincided with positive price movement and 1 with negative movement. Key topics include acquisition. View all WSRC news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
WSRC Company Profile & Sector Positioning
Western Sierra R (WSRC) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing WSRC often look at related companies in the same sector, including Rising Biosciences (RBII), Hero Technologies Inc (HENC), Evergreen Sustainable Enterprises Inc (EGSE), Owc Pharmaceutical Resh Corp (OWCP), and Cannonau Corp (CNNC). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate WSRC's relative position within its industry.